VTAK supply chain intelligence for Catheter Precision, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Catheter Precision, Inc. (VTAK) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CREATD-INC | CREATD-INC | 92% | the Company agreed to acquire from Creatd (i) 800,200 shares of the issued and outstanding common stock, par value $0.001 per share, of Fly Flyte, Inc. |
| SEG-JETS-LLC | SEG-JETS-LLC | 92% | the Company agreed to purchase from SEG Jets common stock of Fly Flyte, Inc. in consideration for the Company agreeing to issue and sell in a private placement 5,250 shares of the Company's preferred stock |
| VOLATO-GROUP-INC | VOLATO-GROUP-INC | 92% | As consideration for the Company’s participation in the Private Placement, Volato has agreed to deliver to the Company certain freely tradeable equity securities of a third-party entity, as further d… |
| PEACS-NV | PEACS-NV | 80% | we entered into a certain Software and Technology License Agreement with PEACS, NV, a Netherlands company |
| ABT | Abbott Laboratories | 72% | Reciprocal relationship from ABT graph: Reciprocal relationship from VTAK graph: Reciprocal relationship from ABT graph: Reciprocal relationship from VTAK graph: luoroscopy systems (similar to x-ray … |
| ABT | Abbott Laboratories | 72% | luoroscopy systems (similar to x-ray in real time). The EP market includes large medical device companies such as Medtronic, Plc., Abbott Laboratories, Biosense-Webster (J&J) and Boston Scientific Co… |
| JNJ | Johnson & Johnson | 72% | Reciprocal relationship from JNJ graph: Reciprocal relationship from VTAK graph: gulatory agencies. Our products may be subject to additional recalls, revocations or suspensions after receiving FDA o… |
| JNJ | Johnson & Johnson | 72% | gulatory agencies. Our products may be subject to additional recalls, revocations or suspensions after receiving FDA or foreign approval or clearance, which could divert managerial and financial reso… |
| CARDIONOMIX | CARDIONOMIX | 70% | Cardionomix acquired the CPNS System |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ABT | Abbott Laboratories | 72% | Reciprocal relationship from ABT graph: Reciprocal relationship from VTAK graph: luoroscopy systems (similar to x-ray in real time). The EP market includes large medical device companies such as Medt… |
| ABT | Abbott Laboratories | 72% | luoroscopy systems (similar to x-ray in real time). The EP market includes large medical device companies such as Medtronic, Plc., Abbott Laboratories, Biosense-Webster (J&J) and Boston Scientific Co… |
| JNJ | Johnson & Johnson | 72% | gulatory agencies. Our products may be subject to additional recalls, revocations or suspensions after receiving FDA or foreign approval or clearance, which could divert managerial and financial reso… |
| JNJ | Johnson & Johnson | 72% | Reciprocal relationship from JNJ graph: Reciprocal relationship from VTAK graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from VTAK graph: Reciprocal relationship from JNJ grap… |
| BOSTON-SCIENTIFIC-CORP | BOSTON-SCIENTIFIC-CORP | 62% | s (similar to x-ray in real time). The EP market includes large medical device companies such as Medtronic, Plc., Abbott Laboratories, Biosense-Webster (J&J) and Boston Scientific Corp. LockeT’s dire… |
| BSX | Boston Scientific Corporation | 62% | Reciprocal relationship from BSX graph: Reciprocal relationship from VTAK graph: Reciprocal relationship from BSX graph: Reciprocal relationship from VTAK graph: s (similar to x-ray in real time). Th… |
| CARDIOFRONT-LLC | CARDIOFRONT-LLC | 62% | e designed to serve underserved regional markets. 54 Table of Contents Recent Developments PeriKard Asset Acquisition On January 14, 2025, we entered into a Membership Interest Purchase Agreement ("A… |
| CATHETER-PRECISION-INC-OVERVIEW-CATHETER-PRECISI | CATHETER-PRECISION-INC-OVERVIEW-CATHETER-PRECISI | 62% | articular the imposition of new or higher tariffs, could place pressure on our average selling prices as our customers seek to offset the impact of increased tariffs on their own products; increased … |
| FLY-FLYTE-INC | FLY-FLYTE-INC | 62% | aviation services. Fly Flyte, Inc. (“FLYTE”) historically has generally provided private aviation services to individuals and individual entities on a per-trip basis, without use of a membership-only… |
| PERIKARD-LLC | PERIKARD-LLC | 62% | e designed to serve underserved regional markets. 54 Table of Contents Recent Developments PeriKard Asset Acquisition On January 14, 2025, we entered into a Membership Interest Purchase Agreement ("A… |
| PONDEROSA-AIR-LLC | PONDEROSA-AIR-LLC | 62% | ffect on our business, financial condition and results of operations. The issuance of operating restrictions applicable to one of the aircraft fleet types FLYTE operates, or on which FLYTE ’ s third-… |
| SEG-JETS-LLC | SEG-JETS-LLC | 62% | lty equal to 11.82 % of net sales of its LockeT device on a quarterly basis, commencing upon the first commercial sale, which occurred in April 2024, through December 31, 2035. In April 2025, a US pa… |
| STRATOSPHERE-DEVELOPMENT-CO-LLC | STRATOSPHERE-DEVELOPMENT-CO-LLC | 62% | lty equal to 11.82 % of net sales of its LockeT device on a quarterly basis, commencing upon the first commercial sale, which occurred in April 2024, through December 31, 2035. In April 2025, a US pa… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| VTAK-DEBT-13457 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| VTAK-DEBT-13456 | Warrants outstanding: 20502073 | 90% | xbrl warrant detail from xbrl 2025-12-31. |
| VTAK-DEBT | Debt stack $9.6M | 90% | Market cache reports total debt of $9.6M. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| IVA | Inventiva S.A. | 100.00 | 2 | |
| MTLS | Materialise NV | 100.00 | 2 | |
| GIKLY | Grifols, S.A. | 100.00 | 2 | |
| GIFOF | Grifols, S.A. | 100.00 | 2 | |
| IINN | Inspira Technologies Oxy B.H.N. Ltd. | 100.00 | 2 | |
| NVS | Novartis AG | 100.00 | 2 | |
| GRFS | Grifols, S.A. | 100.00 | 2 | |
| FLGT | Fulgent Genetics, Inc. | 100.00 | 2 | |
| EXAS | Exact Sciences Corp | 100.00 | 2 | |
| GRAL | GRAIL, Inc. | 100.00 | 2 | |
| GIFLF | Grifols, S.A. | 100.00 | 2 | |
| ITGR | Integer Holdings Corporation | 100.00 | 2 | |
| NBP | NovaBridge Biosciences | 100.00 | 2 | |
| ALVO | Alvotech | 100.00 | 2 | |
| AORT | Artivion, Inc. | 100.00 | 2 | |
| GCTK | GlucoTrack, Inc. | 100.00 | 2 | |
| BSX | Boston Scientific Corporation | 100.00 | 1 | ['customer'] |
| PSNL | Personalis, Inc. | 100.00 | 2 | |
| SVA | Sinovac Biotech Ltd. | 100.00 | 2 | |
| NSPR | InspireMD, Inc. | 100.00 | 2 |